Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYClaritas (formerly Kalytera Therapeutics, Inc.) Announces Addition of Professor Salvatore Cuzzocrea, Ph.D. to the Company’s Board of DirectorsPREV STORYLifeMD Q1 2021 Revenues on Track to Exceed $17 Million, up 295%, with Subscriptions Representing More than 80% of Total Revenue
